TMCnet News
Research and Markets: Human Papillomavirus Infections - Pipeline Review, H2 2014Research and Markets (http://www.researchandmarkets.com/research/jr63kf/human) has announced the addition of the "Human Papillomavirus Infections - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections and special features on late-stage and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary database, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Reasons to buy
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/jr63kf/human
|